The Scientist

» FDA and culture

Most Recent

image: Battling the Bulge

Battling the Bulge

By | November 1, 2015

Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | November 1, 2015

The Psychology of Overeating, The Hidden Half of Nature, The Death of Cancer, and The Secret of Our Success

0 Comments

image: 2015 Life Sciences Salary Survey

2015 Life Sciences Salary Survey

By and | November 1, 2015

This year’s survey highlights dramatic regional, sector, and gender variations.

13 Comments

image: Following FDA OK, 23andMe to Expand Health Prediction

Following FDA OK, 23andMe to Expand Health Prediction

By | October 21, 2015

The personal genomics firm is ramping up its suite of disease-related genetic tests.

0 Comments

image: Scientists Skip Cell Line Validation

Scientists Skip Cell Line Validation

By | October 12, 2015

Despite known problems with contamination and mislabeled cell lines, most researchers continue to operate without authenticating cells’ identity.

2 Comments

image: Debating the Value of Anonymity

Debating the Value of Anonymity

By | October 5, 2015

PubPeer responds to criticism that anonymous post-publication peer review threatens the scientific process.

1 Comment

image: Ready, Willing, and Able

Ready, Willing, and Able

By | October 1, 2015

Researchers with disabilities are making their fields more accessible.

0 Comments

image: FDA Warns Liquid Biopsy Maker

FDA Warns Liquid Biopsy Maker

By | September 25, 2015

The agency fires off a letter to Pathway Genomics, telling the company that its new cancer detection test could harm the public and is not validated by science.

0 Comments

image: Study: Men Get Bigger Start-Up Packages

Study: Men Get Bigger Start-Up Packages

By | September 17, 2015

A new analysis reveals yet another gender gap in science.

0 Comments

image: Duke Cardiologist Tapped to Lead FDA

Duke Cardiologist Tapped to Lead FDA

By | September 17, 2015

The Obama administration has nominated Robert Califf, a researcher who conducted large clinical trials, as the next person to head the country’s drug approval agency.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech